SCHEMBL28157366

SCHEMBL28157366

CN(CC1CC1)S(=O)(=O)c1ccc(NC(=O)c2ccccc2F)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.41
▸ LMNA P02545 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ RAB9A P51151 5/20 0.39
▸ NPC1 O15118 4/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ TP53 P04637 3/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ HTT P42858 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28157321 0.84 TP53 (0.44) MAPTLMNAPOLBRAB9ANPC1
SCHEMBL28156782 0.83 LMNA (0.42) MAPTLMNAPOLBRAB9ANPC1
SCHEMBL28156802 0.83 HDAC4 (0.54) MAPTLMNAPOLBRAB9ATP53
SCHEMBL28156810 0.82 MAPT (0.42) MAPTLMNAPOLBRAB9ANPC1
SCHEMBL16246499 0.81 CFTR (0.50) MAPTLMNAPOLBRAB9ANPC1
SCHEMBL28157313 0.80 RXFP1 (0.46) MAPTLMNAPOLBTP53MEN1
SCHEMBL28846370 0.80 GSTO1 (0.42) MAPTLMNAPOLBRAB9ANPC1
SCHEMBL28157364 0.80 LMNA (0.45) MAPTLMNAPOLBRAB9ANPC1
SCHEMBL28156807 0.79 MEN1 (0.53) MAPTPOLBRAB9ANPC1TP53
SCHEMBL28157305 0.77 MEN1 (0.48) MAPTLMNAPOLBRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 — — CN disclosed
Send feedback